Citigroup’s Avidity Biosciences RNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $1.28M | Sell |
|
|||||
|
2025
Q2 | $8.23M | Sell |
|
|||||
|
2025
Q1 | $11.1M | Buy |
|
|||||
|
2024
Q4 | $5.52M | Buy |
|
|||||
|
2024
Q3 | $5.13M | Buy |
|
|||||
|
2024
Q2 | $1.79M | Sell |
|
|||||
|
2024
Q1 | $6.02M | Buy |
|
|||||
|
2023
Q4 | $775K | Sell |
|
|||||
|
2023
Q3 | $909K | Sell |
|
|||||
|
2023
Q2 | $1.98M | Sell |
|
|||||
|
2023
Q1 | $3.91M | Buy |
|
|||||
|
2022
Q4 | $2.55M | Buy |
|
|||||
|
2022
Q3 | $1.11M | Buy |
|
|||||
|
2022
Q2 | $817K | Buy |
|
|||||
|
2022
Q1 | $511K | Sell |
|
|||||
|
2021
Q4 | $1.75M | Buy |
|
|||||
|
2021
Q3 | $1.46M | Sell |
|
|||||
|
2021
Q2 | $2.58M | Buy |
|
|||||
|
2021
Q1 | $1.67M | Buy |
|
|||||
|
2020
Q4 | $131K | Buy |
|
|||||
|
2020
Q3 | $23K | Buy |
|